FI112668B - Bacillus-promoottori, joka on peräisin Bacillus licheniformis x-amylaasipromoottorimuunnelmasta - Google Patents

Bacillus-promoottori, joka on peräisin Bacillus licheniformis x-amylaasipromoottorimuunnelmasta Download PDF

Info

Publication number: FI112668B
Authority: FI; Finland
Prior art keywords: bacillus; promoter; sequence; eller; gene
Prior art date: 1991-11-14

Application number

FI942228A

Other languages

English (en)

Finnish (fi)

Swedish (sv)

Other versions

FI942228L (fi

FI942228A0 (fi

Inventor

Steen Troels Joergensen

Boerge Krag Diderichsen

Original Assignee

Novozymes As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-11-14

Filing date

1994-05-13

Publication date

2003-12-31

1994-05-13 Application filed by Novozymes As filed Critical Novozymes As

1994-05-13 Publication of FI942228A0 publication Critical patent/FI942228A0/fi

1994-07-13 Publication of FI942228L publication Critical patent/FI942228L/fi

2003-12-31 Application granted granted Critical

2003-12-31 Publication of FI112668B publication Critical patent/FI112668B/fi

Links

241000193830 Bacillus <bacterium> Species 0.000 title claims abstract description 29
241000194108 Bacillus licheniformis Species 0.000 title claims description 29
239000004382 Amylase Substances 0.000 title description 9
108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 9
108090000623 proteins and genes Proteins 0.000 claims description 57
108020004414 DNA Proteins 0.000 claims description 28
108010025880 Cyclomaltodextrin glucanotransferase Proteins 0.000 claims description 27
108090000637 alpha-Amylases Proteins 0.000 claims description 21
102000004169 proteins and genes Human genes 0.000 claims description 17
235000014469 Bacillus subtilis Nutrition 0.000 claims description 16
229940024171 alpha-amylase Drugs 0.000 claims description 13
108010076504 Protein Sorting Signals Proteins 0.000 claims description 12
102000004139 alpha-Amylases Human genes 0.000 claims description 12
239000013598 vector Substances 0.000 claims description 11
238000004519 manufacturing process Methods 0.000 claims description 8
238000013518 transcription Methods 0.000 claims description 6
230000035897 transcription Effects 0.000 claims description 6
108010029675 Bacillus licheniformis alpha-amylase Proteins 0.000 claims description 5
102000004190 Enzymes Human genes 0.000 claims description 4
108090000790 Enzymes Proteins 0.000 claims description 4
229940088598 enzyme Drugs 0.000 claims description 4
241000193744 Bacillus amyloliquefaciens Species 0.000 claims description 3
241000193749 Bacillus coagulans Species 0.000 claims description 2
241000193422 Bacillus lentus Species 0.000 claims description 2
241000193764 Brevibacillus brevis Species 0.000 claims description 2
241000193385 Geobacillus stearothermophilus Species 0.000 claims description 2
108091005804 Peptidases Proteins 0.000 claims description 2
239000004365 Protease Substances 0.000 claims description 2
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 2
229940054340 bacillus coagulans Drugs 0.000 claims description 2
239000013604 expression vector Substances 0.000 claims description 2
244000063299 Bacillus subtilis Species 0.000 claims 1
230000001737 promoting effect Effects 0.000 claims 1
238000003259 recombinant expression Methods 0.000 claims 1
238000009877 rendering Methods 0.000 claims 1
239000013612 plasmid Substances 0.000 description 64
239000012634 fragment Substances 0.000 description 25
101100055551 Bacillus licheniformis amyS gene Proteins 0.000 description 17
101100216056 Lactobacillus amylovorus amyL gene Proteins 0.000 description 17
229930027917 kanamycin Natural products 0.000 description 17
229960000318 kanamycin Drugs 0.000 description 17
SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 17
229930182823 kanamycin A Natural products 0.000 description 17
-1 amyL Chemical class 0.000 description 16
210000004027 cell Anatomy 0.000 description 15
235000018102 proteins Nutrition 0.000 description 12
241000588724 Escherichia coli Species 0.000 description 10
238000000034 method Methods 0.000 description 10
101150114960 cgtA gene Proteins 0.000 description 9
229960005091 chloramphenicol Drugs 0.000 description 9
WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 9
230000004927 fusion Effects 0.000 description 9
230000001131 transforming effect Effects 0.000 description 9
229960000723 ampicillin Drugs 0.000 description 8
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 8
101150039703 amyL gene Proteins 0.000 description 8
230000006798 recombination Effects 0.000 description 8
238000005215 recombination Methods 0.000 description 8
230000010076 replication Effects 0.000 description 8
230000009466 transformation Effects 0.000 description 8
101100027828 Caulobacter vibrioides (strain ATCC 19089 / CB15) obg gene Proteins 0.000 description 6
ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 6
101100188475 Escherichia coli (strain K12) obgE gene Proteins 0.000 description 6
108091034117 Oligonucleotide Proteins 0.000 description 6
230000000694 effects Effects 0.000 description 6
108020004707 nucleic acids Proteins 0.000 description 6
102000039446 nucleic acids Human genes 0.000 description 6
150000007523 nucleic acids Chemical class 0.000 description 6
230000002759 chromosomal effect Effects 0.000 description 5
210000000349 chromosome Anatomy 0.000 description 5
230000010354 integration Effects 0.000 description 5
210000001938 protoplast Anatomy 0.000 description 5
108010065511 Amylases Proteins 0.000 description 4
238000004458 analytical method Methods 0.000 description 4
238000010276 construction Methods 0.000 description 4
238000001727 in vivo Methods 0.000 description 4
239000002609 medium Substances 0.000 description 4
239000002773 nucleotide Substances 0.000 description 4
125000003729 nucleotide group Chemical group 0.000 description 4
238000011144 upstream manufacturing Methods 0.000 description 4
102000013142 Amylases Human genes 0.000 description 3
108091005658 Basic proteases Proteins 0.000 description 3
108091026890 Coding region Proteins 0.000 description 3
108091035707 Consensus sequence Proteins 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
229920002472 Starch Polymers 0.000 description 3
241000186338 Thermoanaerobacter sp. Species 0.000 description 3
235000019418 amylase Nutrition 0.000 description 3
238000003776 cleavage reaction Methods 0.000 description 3
238000012217 deletion Methods 0.000 description 3
230000037430 deletion Effects 0.000 description 3
229960003276 erythromycin Drugs 0.000 description 3
239000000499 gel Substances 0.000 description 3
238000010369 molecular cloning Methods 0.000 description 3
230000035772 mutation Effects 0.000 description 3
239000000047 product Substances 0.000 description 3
230000007017 scission Effects 0.000 description 3
238000010561 standard procedure Methods 0.000 description 3
235000019698 starch Nutrition 0.000 description 3
239000008107 starch Substances 0.000 description 3
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
108700039691 Genetic Promoter Regions Proteins 0.000 description 2
239000006142 Luria-Bertani Agar Substances 0.000 description 2
238000012408 PCR amplification Methods 0.000 description 2
108020004511 Recombinant DNA Proteins 0.000 description 2
101100072644 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) INO2 gene Proteins 0.000 description 2
101100454372 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) LCB2 gene Proteins 0.000 description 2
101100489624 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) RTS1 gene Proteins 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
241000186339 Thermoanaerobacter Species 0.000 description 2
108700009124 Transcription Initiation Site Proteins 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
238000002474 experimental method Methods 0.000 description 2
235000013312 flour Nutrition 0.000 description 2
230000012010 growth Effects 0.000 description 2
238000002744 homologous recombination Methods 0.000 description 2
230000006801 homologous recombination Effects 0.000 description 2
238000011534 incubation Methods 0.000 description 2
238000003780 insertion Methods 0.000 description 2
230000037431 insertion Effects 0.000 description 2
229910052740 iodine Inorganic materials 0.000 description 2
239000011630 iodine Substances 0.000 description 2
238000001155 isoelectric focusing Methods 0.000 description 2
238000012986 modification Methods 0.000 description 2
230000004048 modification Effects 0.000 description 2
101150066583 rep gene Proteins 0.000 description 2
108091008146 restriction endonucleases Proteins 0.000 description 2
238000012807 shake-flask culturing Methods 0.000 description 2
238000002741 site-directed mutagenesis Methods 0.000 description 2
NWXMGUDVXFXRIG-WESIUVDSSA-N (4s,4as,5as,6s,12ar)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O NWXMGUDVXFXRIG-WESIUVDSSA-N 0.000 description 1
101150055869 25 gene Proteins 0.000 description 1
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
229930195573 Amycin Natural products 0.000 description 1
244000144725 Amygdalus communis Species 0.000 description 1
101100283604 Caenorhabditis elegans pigk-1 gene Proteins 0.000 description 1
102000011632 Caseins Human genes 0.000 description 1
108010076119 Caseins Proteins 0.000 description 1
102000012410 DNA Ligases Human genes 0.000 description 1
108010061982 DNA Ligases Proteins 0.000 description 1
241000282326 Felis catus Species 0.000 description 1
241001123946 Gaga Species 0.000 description 1
244000068988 Glycine max Species 0.000 description 1
235000010469 Glycine max Nutrition 0.000 description 1
240000005979 Hordeum vulgare Species 0.000 description 1
235000007340 Hordeum vulgare Nutrition 0.000 description 1
238000000636 Northern blotting Methods 0.000 description 1
108020005187 Oligonucleotide Probes Proteins 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
108020005091 Replication Origin Proteins 0.000 description 1
241000220317 Rosa Species 0.000 description 1
238000012300 Sequence Analysis Methods 0.000 description 1
238000002105 Southern blotting Methods 0.000 description 1
239000004098 Tetracycline Substances 0.000 description 1
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
239000002253 acid Substances 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
239000008272 agar Substances 0.000 description 1
239000011543 agarose gel Substances 0.000 description 1
101150105363 amyE gene Proteins 0.000 description 1
238000003556 assay Methods 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
108010019077 beta-Amylase Proteins 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
229940041514 candida albicans extract Drugs 0.000 description 1
230000010261 cell growth Effects 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
239000013611 chromosomal DNA Substances 0.000 description 1
238000010367 cloning Methods 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
238000000576 coating method Methods 0.000 description 1
239000002299 complementary DNA Substances 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
239000012228 culture supernatant Substances 0.000 description 1
239000000706 filtrate Substances 0.000 description 1
238000001914 filtration Methods 0.000 description 1
238000007429 general method Methods 0.000 description 1
108010061330 glucan 1,4-alpha-maltohydrolase Proteins 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
238000009396 hybridization Methods 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
238000002955 isolation Methods 0.000 description 1
239000003550 marker Substances 0.000 description 1
230000001404 mediated effect Effects 0.000 description 1
108020004999 messenger RNA Proteins 0.000 description 1
239000000203 mixture Substances 0.000 description 1
239000000178 monomer Substances 0.000 description 1
230000007659 motor function Effects 0.000 description 1
239000002751 oligonucleotide probe Substances 0.000 description 1
238000012261 overproduction Methods 0.000 description 1
229920001983 poloxamer Polymers 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
229920001592 potato starch Polymers 0.000 description 1
230000001376 precipitating effect Effects 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
238000011027 product recovery Methods 0.000 description 1
235000004252 protein component Nutrition 0.000 description 1
230000001172 regenerating effect Effects 0.000 description 1
230000008929 regeneration Effects 0.000 description 1
238000011069 regeneration method Methods 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
230000028327 secretion Effects 0.000 description 1
238000012163 sequencing technique Methods 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229940080237 sodium caseinate Drugs 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
238000006467 substitution reaction Methods 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
229960002180 tetracycline Drugs 0.000 description 1
229930101283 tetracycline Natural products 0.000 description 1
235000019364 tetracycline Nutrition 0.000 description 1
150000003522 tetracyclines Chemical class 0.000 description 1
230000002103 transcriptional effect Effects 0.000 description 1
238000012546 transfer Methods 0.000 description 1
239000007160 ty medium Substances 0.000 description 1
239000012138 yeast extract Substances 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
- C12N9/2411—Amylases
- C12N9/2414—Alpha-amylase (3.2.1.1.)
- C12N9/2417—Alpha-amylase (3.2.1.1.) from microbiological source
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/75—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1051—Hexosyltransferases (2.4.1)
- C12N9/1074—Cyclomaltodextrin glucanotransferase (2.4.1.19)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
- C12N9/54—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Organic Chemistry (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
General Engineering & Computer Science (AREA)
Microbiology (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Physics & Mathematics (AREA)
Biophysics (AREA)
Plant Pathology (AREA)
Chemical Kinetics & Catalysis (AREA)
Oil, Petroleum & Natural Gas (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Enzymes And Modification Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Devices For Conveying Motion By Means Of Endless Flexible Members (AREA)

FI942228A 1991-11-14 1994-05-13 Bacillus-promoottori, joka on peräisin Bacillus licheniformis x-amylaasipromoottorimuunnelmasta FI112668B (fi)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
DK9100343		1991-11-14
DK9100343		1991-11-14
PCT/DK1992/000338 WO1993010249A1 (fr)	1991-11-14	1992-11-13	Promoteur de bacillus derive d'un variant d'un promoteur de bacillus licheniformis x-amylase
DK9200338		1992-11-13

Publications (3)

Publication Number	Publication Date
FI942228A0 FI942228A0 (fi)	1994-05-13
FI942228L FI942228L (fi)	1994-07-13
FI112668B true FI112668B (fi)	2003-12-31

Family

ID=8153698

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI942228A FI112668B (fi)	1991-11-14	1994-05-13	Bacillus-promoottori, joka on peräisin Bacillus licheniformis x-amylaasipromoottorimuunnelmasta

Country Status (11)

Country	Link
US (1)	US5698415A (fr)
EP (1)	EP0667910B1 (fr)
JP (1)	JP3529774B2 (fr)
AT (1)	ATE248223T1 (fr)
AU (1)	AU661070B2 (fr)
CA (1)	CA2123496C (fr)
DE (1)	DE69233178T2 (fr)
DK (1)	DK0667910T3 (fr)
FI (1)	FI112668B (fr)
IL (1)	IL103750A0 (fr)
WO (1)	WO1993010249A1 (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5955310A (en) *	1998-02-26	1999-09-21	Novo Nordisk Biotech, Inc.	Methods for producing a polypeptide in a bacillus cell
US6300115B1 (en)	1998-05-18	2001-10-09	Enzyme Bio-Systems Ltd.	Pullulanase expression constructs containing α-amylase promoter and leader sequences
US7521204B2 (en)	2002-04-10	2009-04-21	Novozymes A/S	Bacillus host cell
EP1696035A3 (fr)	2002-04-10	2008-04-02	Novozymes A/S	Cellule hôte de bacille améliorée
WO2004101759A2 (fr)	2003-05-12	2004-11-25	Genencor International, Inc.	Nouvelle enzyme lipolytique lip2
EP1625202A4 (fr)	2003-05-12	2010-10-20	Genencor Int	Enzyme lipolytique lip1
WO2004111224A1 (fr)	2003-06-19	2004-12-23	Novozymes A/S	Proteases ameliorees et procedes de production de ces dernieres
CN101426925A (zh) *	2004-03-31	2009-05-06	诺维信生物聚合物公司	在芽孢杆菌细胞中生产透明质酸的方法
WO2005123915A1 (fr)	2004-06-21	2005-12-29	Novozymes A/S	Copies multiples d'au moins deux cadres de lecture ouverte maintenus stables dans la meme orientation
CN101611145B (zh)	2006-12-21	2013-08-14	诺维信股份有限公司	用于在细菌细胞中表达基因的修饰型信使rna稳定化序列
BRPI0809096A2 (pt)	2007-03-23	2014-09-09	Danisco Us Inc Genecor Division	Produção aumentada de amilase através da adição n-terminal à proteína amilase madura
US7618801B2 (en)	2007-10-30	2009-11-17	Danison US Inc.	Streptomyces protease
KR101683302B1 (ko)	2008-03-28	2016-12-06	다니스코 유에스 인크.	박테리아 세포 내 로커스 증폭 방법
JPWO2010082619A1 (ja)	2009-01-16	2012-07-05	大塚化学株式会社	高発現プロモーターおよびこれを用いた遺伝子産物製造法
WO2010097436A1 (fr)	2009-02-27	2010-09-02	Novozymes A/S	Cellules mutantes à expression réduite de la métallopeptidase, appropriées pour la production de polypeptides recombinés
AR076941A1 (es)	2009-06-11	2011-07-20	Danisco Us Inc	Cepa de bacillus para una mayor produccion de proteina
WO2011000924A1 (fr)	2009-07-03	2011-01-06	Abbott Products Gmbh	Amylase séchée par pulvérisation, préparations pharmaceutiques la comprenant et son utilisation
CN102762723A (zh)	2009-12-21	2012-10-31	诺维信股份有限公司	用于在巯基-二硫键氧还酶缺陷的细菌突变体细胞中产生异源多肽的方法
CN103443278B (zh)	2011-03-23	2017-07-04	诺维信公司	生产分泌型多肽的方法
CN106754833B (zh) *	2017-01-16	2020-06-09	广东溢多利生物科技股份有限公司	在枯草芽孢杆菌中高效表达普鲁兰酶的方法及重组枯草芽孢杆菌
US20200318086A1 (en)	2017-11-10	2020-10-08	Novozymes A/S	Temperature-sensitive cas9 protein
US20210017544A1 (en)	2017-12-22	2021-01-21	Novozymes A/S	Counter-Selection by Inhibition of Conditionally Essential Genes
EP3927837A1 (fr)	2019-02-20	2021-12-29	Basf Se	Procédé de fermentation industrielle pour bacillus utilisant un milieu défini et une alimentation en magnésium
MX2021010109A (es)	2019-02-20	2021-09-21	Basf Se	Proceso de fermentacion industrial para bacillus mediante el uso de un medio definido y una alimentacion de oligoelementos.
EP3969576A1 (fr)	2019-05-15	2022-03-23	Novozymes A/S	Endonucléase guidée par arn sensible à la température
CN114207125B (zh)	2019-06-25	2025-01-28	诺维信公司	通过抑制条件性必需基因进行反向选择
WO2022018260A1 (fr)	2020-07-24	2022-01-27	Basf Se	Délétion unique et transcomplémentation de l'alanine racémase
EP4189103A1 (fr)	2020-07-28	2023-06-07	Basf Se	Procédé de fermentation industrielle pour bacillus utilisant un décalage de température
MX2023001273A (es)	2020-07-28	2023-03-03	Basf Se	Proceso de fermentacion industrial para bacillus mediante el uso de cambio de velocidad de alimentacion.
BR112023001392A2 (pt)	2020-07-28	2023-02-14	Basf Se	Método para produzir uma proteína de interesse a partir de uma célula hospedeira de bacillus
US20230331775A1 (en)	2020-09-22	2023-10-19	Basf Se	Method for recovering a protein from a fermentation broth comprising a high degree of lysed cells
EP4225779A2 (fr)	2020-10-07	2023-08-16	Basf Se	Cellule de bacillus présentant des activités annexes réduites de lipase et/ou d'estérase
EP4263822A1 (fr)	2020-12-15	2023-10-25	Novozymes A/S	Cellules hôtes mutées à motilité cellulaire réduite
MX2023015460A (es)	2021-06-24	2024-01-18	Basf Se	Celula huesped de bacillus mejorada con proteina rema/remb alterada.
WO2022269082A1 (fr)	2021-06-24	2022-12-29	Basf Se	Hôte de production de bacillus amélioré
EP4359423A1 (fr)	2021-06-24	2024-05-01	Basf Se	Cellule hôte de bacillus licheniformis pour la production d'un composé d'intérêt avec une pureté accrue
US20250051822A1 (en)	2021-12-20	2025-02-13	Basf Se	Method for improved production of intracellular proteins in bacillus
CN119630806A (zh)	2022-08-02	2025-03-14	巴斯夫欧洲公司	使用芽孢杆菌属宿主细胞与盐进料的稳定的蛋白质生产方法
CN120500529A (zh)	2023-01-05	2025-08-15	巴斯夫欧洲公司	折叠酶用于改善分泌分子的异源表达的用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4769327A (en) *	1985-03-29	1988-09-06	Biotechnica International, Inc.	Secretion vector

1992
- 1992-11-13 WO PCT/DK1992/000338 patent/WO1993010249A1/fr active IP Right Grant
- 1992-11-13 DK DK92923722T patent/DK0667910T3/da active
- 1992-11-13 EP EP92923722A patent/EP0667910B1/fr not_active Expired - Lifetime
- 1992-11-13 DE DE69233178T patent/DE69233178T2/de not_active Expired - Lifetime
- 1992-11-13 IL IL103750A patent/IL103750A0/xx unknown
- 1992-11-13 CA CA002123496A patent/CA2123496C/fr not_active Expired - Lifetime
- 1992-11-13 AU AU29430/92A patent/AU661070B2/en not_active Ceased
- 1992-11-13 JP JP50889993A patent/JP3529774B2/ja not_active Expired - Lifetime
- 1992-11-13 AT AT92923722T patent/ATE248223T1/de not_active IP Right Cessation
- 1992-11-13 US US08/240,748 patent/US5698415A/en not_active Expired - Lifetime
1994
- 1994-05-13 FI FI942228A patent/FI112668B/fi not_active IP Right Cessation

Also Published As

Publication number	Publication date
CA2123496A1 (fr)	1993-05-27
CA2123496C (fr)	2004-02-03
DK0667910T3 (da)	2003-12-01
EP0667910A1 (fr)	1995-08-23
FI942228L (fi)	1994-07-13
WO1993010249A1 (fr)	1993-05-27
FI942228A0 (fi)	1994-05-13
AU661070B2 (en)	1995-07-13
IL103750A0 (en)	1993-04-04
AU2943092A (en)	1993-06-15
JP3529774B2 (ja)	2004-05-24
US5698415A (en)	1997-12-16
DE69233178D1 (de)	2003-10-02
ATE248223T1 (de)	2003-09-15
DE69233178T2 (de)	2004-06-17
EP0667910B1 (fr)	2003-08-27
JPH07504085A (ja)	1995-05-11

Publication	Publication Date	Title
FI112668B (fi)	2003-12-31	Bacillus-promoottori, joka on peräisin Bacillus licheniformis x-amylaasipromoottorimuunnelmasta
Jørgensen et al.	1991	Cloning, sequence, and expression of a lipase gene from Pseudomonas cepacia: lipase production in heterologous hosts requires two Pseudomonas genes
EP1297170B1 (fr)	2016-03-02	Technique relative a une integration a copies multiples chromosomique stable de genes
YUUKT et al.	1985	Complete nucleotide sequence of a gene coding for heat-and pH-stable α-amylase of Bacillus licheniformis: comparison of the amino acid sequences of three bacterial liquefying α-amylases deduced from the DNA sequences
FI112502B (fi)	2003-12-15	DNA:n siirtäminen stabiilisti bakteerien perimään
Shimotsu et al.	1986	Modulation of Bacillus subtilis levansucrase gene expression by sucrose and regulation of the steady-state mRNA level by sacU and sacQ genes
Rygus et al.	1992	Catabolite repression of the xyl operon in Bacillus megaterium
LT4000B (en)	1996-06-25	Expression module, transformed host cell, process for preparing serine protease, method of transformation, dna sequence, plasmid, oligonucleotide
JPH0829091B2 (ja)	1996-03-27	ハイブリッドｐｍａ配列の製造方法及び該方法に使用するベクター
JPH08504585A (ja)	1996-05-21	Ｄｎａ増幅
EP0487541B1 (fr)	1994-08-31	Adn encodant une lipase et un modulateur de lipase
Guerrero et al.	1994	Directed mutagenesis of a regulatory palindromic sequence upstream from the Brevibacterium lactofermentum tryptophan operon
Oskam et al.	1991	The large Bacillus plasmid pTB19 contains two integrated rolling-circle plasmids carrying mobilization functions
US6100063A (en)	2000-08-08	Procaryotic cell comprising at least two copies of a gene
Iordanescu	1989	Specificity of the interactions between the Rep proteins and the origins of replication of Staphylococcus aureus plasmids pT181 and pC221
WO1993010248A1 (fr)	1993-05-27	PROCEDE D'EXPRESSION DES GENES DANS $i(BACILLUS LICHENIFORMIS)
EP1062318B1 (fr)	2004-04-28	Cellule procaryote comprenant deux copies d'un gene transcrites dans des directions differentes
Kitamoto et al.	1992	Cloning and sequencing of the gene encoding cyclodextrin glucanotransferase from Bacillus sp. KC201
CN1322138C (zh)	2007-06-20	用于基因的稳定的染色体多拷贝整合的方法
US5264350A (en)	1993-11-23	DNA sequence performing a function which is expressed in an over-production of extracellular proteins by various strains of bacillus, and vectors containing this sequence
JP2000078981A (ja)	2000-03-21	Ｄｎａ断片
Lam	1999	Application of novel Bacillus subtilis systems to efficient secretory production of heterologous proteins
JPH0695940B2 (ja)	1994-11-30	枯草菌およびその形成方法
FR2629097A1 (fr)	1989-09-29	Sequence d'adn comprenant la partie fonctionnelle du locus sacu de b. subtilis, vecteurs contenant la sequence correspondante, et leur utilisation dans des procedes de production de proteines
FR2632320A2 (fr)	1989-12-08	Sequence d'adn comprenant la partie fonctionnelle du locus sacu de b. subtilis, vecteurs contenant la sequence correspondante, et leur utilisation dans des procedes de production de proteines

Legal Events

Date	Code	Title	Description
2012-12-20	MA	Patent expired